top of page

IMDRF Guidance: CyberSecurity, Post-Market Surveillance, Personalized Medical Devices


International Medical Device Regulators Forum, is a voluntary group of medical device regulators from around the world who have come together to harmonize regulatory requirements for medical devices.


The goal of IMDRF is to improve the safety, effectiveness, and quality of medical devices by promoting international collaboration and standardization.

Personalized medical devices are those that are customized to fit a specific patient's anatomy, physiology, or pathology. The guidance outlines the key considerations that manufacturers of personalized medical devices should take into account during the production verification and validation process.


The term legacy medical device refers to devices that are no longer in production, have reached the end of their support period, but are still being used for patient care. As these devices were developed before modern cybersecurity best practices were developed, they may not have been designed with cybersecurity in mind when they were designed and manufactured.


In this guidance document, stakeholders will find clear methods for identifying potential legacy medical devices and practical and feasible ways to keep legacy medical devices secure.


This guide provides guidance for the exchange of post-market surveillance (PMS) information among national competent authorities (NCAs) responsible for regulating medical devices. Also, this guidance outlines the criteria and report form that NCAs should use when exchanging PMS information with each other. The guidance also includes recommendations for the content and format of PMS reports to facilitate a consistent and efficient exchange of information.


This guidance aims to help medical device manufacturers and regulators create and implement effective cybersecurity practices through the use of SBOMs. It outlines the principles and practices that should be followed when creating and using SBOMs for medical devices.




I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page